NCT07334431
- Conditions
- Digestive System Diseases, Digestive System Neoplasms, First-line Therapy, +11 more
- Locations
-
- Henan Cancer Hospital (Affiliated Cancer Hospital of Zhengzhou University) Zhengzhou, Henan, China
Clinical trial condition
Fruquintinib
Explore clinical trials studying Fruquintinib. Study availability and eligibility vary by location and protocol.
6 public trials
2 recruiting studies
Fruquintinib trial results
NCT07257653
- Conditions
- BRAF, Cetuximabβ, Colonic Diseases, +12 more
- Locations
-
- Second Affiliated Hospital Zhejiang University College of Medicine, Hangzhou, Zhejiang Province 310999 Hangzhou, Zhejiang, China
Not yet recruiting
MAIC of Fruquintinib Plus Paclitaxel Versus Ramucirumab Plus Paclitaxel in Advanced G/GEJ Adenocarcinoma
NCT07144995
- Conditions
- Advanced Gastric Cancer, Fruquintinib, Gastroesophageal Junction Adenocarcinoma, +1 more
- Locations
-
Not specified
Not yet recruiting
Fruquintinib Combined With PD-1 Inhibitor as First-line Maintenance Therapy for Advanced Gastric Cancer
NCT06888037
- Conditions
- First-line Therapy, Fruquintinib, GEJ Adenocarcinoma, +3 more
- Locations
-
- Ruijin Hospital Shanghai, Shanghai Municipality, China
Not yet recruiting
Fruquintinib Combined With PD-1 Inhibitor and FOLFOX as First-Line Treatment For Advanced Gastric Cancer
NCT06871527
- Conditions
- Digestive System Diseases, Digestive System Neoplasms, Fruquintinib, +11 more
- Locations
-
- The Sixth Affiliated Hospital of Sun Yat-sen University Guangzhou, Guangdong, China
Active, not recruiting
A Phase 2 Trial of Fruquintinib and Tislelizumab in ctDNA-defined Minimal Residual Disease in Colorectal Cancer After Completion of Adjuvant Chemotherapy
NCT07136077
- Conditions
- Adjuvant Chemotherapy, Colonic Diseases, Colorectal Cancer, +18 more
- Locations
-
- MD Anderson Cancer Center Houston, Texas, United States